Author Question: Juan has his corpus callosum severed to prevent whole-brain seizures. Now, he sits in front of a ... (Read 127 times)

jrubin

  • Hero Member
  • *****
  • Posts: 552
Juan has his corpus callosum severed to prevent whole-brain seizures. Now, he sits in front of a screen and stares at a dot in the middle, while simple visual stimuli are flashed briefly to the left and right of the dot. What will Juan be able to do with this stimuli?
 
  a. Juan will be able to name stimuli on the left, but not on the right.
  b. Juan will be able to name stimuli on the right, but not on the left.
  c. Juan will not be able to name any of the stimuli.
  d. Juan will be able to name all of the stimuli.

Question 2

The two hemispheres of the brain sometimes perform different tasks (lateral dominance). However, information is passed back and forth between hemispheres so that the brain can function as a whole. This interhemispheric communication depends on the ____.
 
  a. association cortex
  b. thalamus
  c. somatosensory cortex
  d. corpus callosum



adf223

  • Sr. Member
  • ****
  • Posts: 304
Answer to Question 1

ANSWER:
b

Answer to Question 2

ANSWER:
d



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Pubic lice (crabs) are usually spread through sexual contact. You cannot catch them by using a public toilet.

Did you know?

ACTH levels are normally highest in the early morning (between 6 and 8 A.M.) and lowest in the evening (between 6 and 11 P.M.). Therefore, a doctor who suspects abnormal levels looks for low ACTH in the morning and high ACTH in the evening.

Did you know?

In ancient Rome, many of the richer people in the population had lead-induced gout. The reason for this is unclear. Lead poisoning has also been linked to madness.

Did you know?

Russia has the highest death rate from cardiovascular disease followed by the Ukraine, Romania, Hungary, and Poland.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library